Jing Qin

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Combination Therapy

Locally Advanced

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Clinical and translational medicine

Nature communications

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Yifan Cao, Kuan Yu, Zihao Zhang, Yun Gu, Yichao Gu, Wandi Li, Weijuan Zhang, Zhenbin Shen, Jiejie Xu, Jing Qin
Blockade of V-domain immunoglobulin suppressor of T-cell activation reprograms tumour-associated macrophages and improves efficacy of PD-1 inhibitor in gastric cancer. Clinical and translational medicine 14 (2) (2024)
Yifan Cao, Kuan Yu, Zihao Zhang, Yun Gu, Yichao Gu, Wandi Li, Weijuan Zhang, Zhenbin Shen, Jiejie Xu, Jing Qin
Blockade of V-domain immunoglobulin suppressor of T-cell activation reprograms tumour-associated macrophages and improves efficacy of PD-1 inhibitor in gastric cancer. Clinical and translational medicine 14 (2) (2024)
Yifan Cao, Kuan Yu, Zihao Zhang, Yun Gu, Yichao Gu, Wandi Li, Weijuan Zhang, Zhenbin Shen, Jiejie Xu, Jing Qin
Blockade of V-domain immunoglobulin suppressor of T-cell activation reprograms tumour-associated macrophages and improves efficacy of PD-1 inhibitor in gastric cancer. Clinical and translational medicine 14 (2) (2024)
Yan Li, Chen Xu, Bing Wang, Fu-Jiang Xu, Fahan Ma, Yuanyuan Qu, Dongxian Jiang, Kai Li, Jinwen Feng, Sha Tian, Xiaohui Wu, Yun-Zhi Wang, Yang Liu, Zhaoyu Qin, Yalan Liu, Jing Qin, Qi Song, Xiaolei Zhang, Akesu Sujie, Jie Huang, Tian-Shu Liu, Kuntang Shen, Jian-Yuan Zhao, Ying-Yong Hou, Chen Ding
Author Correction: Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies. Nature communications 13 (1) (2022)
Yan Li, Chen Xu, Bing Wang, Fu-Jiang Xu, Fahan Ma, Yuanyuan Qu, Dongxian Jiang, Kai Li, Jinwen Feng, Sha Tian, Xiaohui Wu, Yun-Zhi Wang, Yang Liu, Zhaoyu Qin, Yalan Liu, Jing Qin, Qi Song, Xiaolei Zhang, Akesu Sujie, Jie Huang, Tian-Shu Liu, Kuntang Shen, Jian-Yuan Zhao, Ying-Yong Hou, Chen Ding
Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategies. Nature communications 13 (1) (2022)
Yue-Da Chen, Botian Ye, Chunyan Wang, Yanyan Nie, Jing Qin, Zhenbin Shen
PLOD3 contributes to HER-2 therapy resistance in gastric cancer through FoxO3/Survivin pathway. Cell death discovery 8 (1) (2022)